Clinical Trial

Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 30, 2025 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
To determine the clinical utility of serum cystatin C in early detection of acute kidney injury (AKI).
Trial Details
NCT Number NCT07197957
Lead Sponsor BayCare Health System
Conditions Acute Kidney Injury
Enrollment 100 participants
Start Date 2025-03-11
Primary Completion 2026-02-28 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-09-30